Dysregulated Signaling Pathways in Canine Mammary Tumor and Human Triple Negative Breast Cancer: Advances and Potential Therapeutic Targets

被引：3

作者：

Mei, Chen ^{[1
]}

Liu, Ying ^{[1
]}

Liu, Zhenyi ^{[1
]}

Zhi, Yan ^{[1
]}

Jiang, Zhaoling ^{[1
]}

Lyu, Xueze ^{[2
]}

Wang, Hongjun ^{[1
]}

机构：

[1] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing 100097, Peoples R China

[2] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2025年 / 26卷 / 01期

关键词：

human breast cancer; canine mammary tumor; signaling pathways; drug targets; EPIDERMAL-GROWTH-FACTOR; NLRP3; INFLAMMASOME; DOUBLE-BLIND; EXPRESSION; APOPTOSIS; ACTIVATION; PACLITAXEL; PD-1;

D O I：

10.3390/ijms26010145

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In 2022, human breast cancer (HBC) and canine mammary tumors (CMTs) remained the most prevalent malignant tumors worldwide, with high recurrence and lethality rates, posing a significant threat to human and dog health. The development of breast cancer involves multiple signaling pathways, highlighting the need for effective inhibitory drugs that target key proteins in these pathways. This article reviews the dysregulation of the EGFR, PI3K/AKT/mTOR, Hippo, pyroptosis, and PD-1/PD-L1 signaling pathways in HBC and CMT, as well as the corresponding drugs used to inhibit tumor growth, with the aim of providing theoretical support for the development of more efficient drugs.

引用

页数：15

共 50 条

[41] Therapeutic potential of PLK1 inhibition in triple-negative breast cancer [J].

Ueda, Ai ;

Oikawa, Keiki ;

Fujita, Koji ;

Ishikawa, Akio ;

Sato, Eiichi ;

Ishikawa, Takashi ;

Kuroda, Masahiko ;

Kanekura, Kohsuke .

LABORATORY INVESTIGATION, 2019, 99 (09) :1275-1286

[42] Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications [J].

Jezequel, Pascal ;

Kerdraon, Olivier ;

Hondermarck, Hubert ;

Guerin-Charbonnel, Catherine ;

Lasla, Hamza ;

Gouraud, Wilfried ;

Canon, Jean-Luc ;

Gombos, Andrea ;

Dalenc, Florence ;

Delaloge, Suzette ;

Lemonnier, Jerome ;

Loussouarn, Delphine ;

Verriele, Veronique ;

Campone, Mario .

BREAST CANCER RESEARCH, 2019, 21 (1)

[43] Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy [J].

Feng, Tingting ;

Cao, Wei ;

Shen, Wanxiang ;

Zhang, Liang ;

Gu, Xinsheng ;

Guo, Yang ;

Tsai, Hsiang-i ;

Liu, Xuewen ;

Li, Jian ;

Zhang, Jingxuan ;

Li, Shan ;

Wu, Fuyun ;

Liu, Ying .

ONCOTARGET, 2017, 8 (01) :329-344

[44] LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer [J].

Lo, Pang-Kuo ;

Yao, Yuan ;

Lee, Ji Shin ;

Zhang, Yongshu ;

Huang, Weiliang ;

Kane, Maureen A. ;

Zhou, Qun .

ELIFE, 2018, 7

[45] Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets [J].

Wang, Xiaosheng ;

Guda, Chittibabu .

MEDICINE, 2016, 95 (30)

[46] Dual Inhibition of Key Proliferation Signaling Pathways in Triple-Negative Breast Cancer Cells by a Novel Derivative of Taiwanin A [J].

Kuo, Yueh-Hsiung ;

Chiang, En-Pei Isabel ;

Chao, Che-Yi ;

Rodriguez, Raymond L. ;

Chou, Pei-Yu ;

Tsai, Shu-Yao ;

Pai, Man-Hui ;

Tang, Feng-Yao .

MOLECULAR CANCER THERAPEUTICS, 2017, 16 (03) :480-493

[47] Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer [J].

Shang, Mao ;

Chang, Chunxiao ;

Pei, Yanqing ;

Guan, Yin ;

Chang, Jin ;

Li, HuiHui .

JOURNAL OF CANCER, 2018, 9 (24) :4627-4634

[48] Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway [J].

Li, Hongzhong ;

Yang, Bing ;

Huang, Jing ;

Xiang, Tingxiu ;

Yin, Xuedong ;

Wan, Jingyuan ;

Luo, Fuling ;

Zhang, Li ;

Li, Hongyuan ;

Ren, Guosheng .

TOXICOLOGY LETTERS, 2013, 220 (03) :219-228

[49] Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways [J].

Tajbakhsh, Amir ;

Hasanzadeh, Malihe ;

Rezaee, Mehdi ;

Khedri, Mostafa ;

Khazaei, Majid ;

ShahidSales, Soodabeh ;

Ferns, Gordon A. ;

Hassanian, Seyed Mahdi ;

Avan, Amir .

JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (03) :2183-2192

[50] Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities [J].

Ribeiro, Rita ;

Carvalho, Maria Joao ;

Goncalves, Joao ;

Moreira, Joao Nuno .

FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9

← 1 2 3 4 5 →